Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Superinvestors holding ASND, Q2 2026
No superinvestor reported holding ASND in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ASND each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- Duquesne Family Office (−40.1%)
Q3 2024
1 superinvestor holding at quarter end
- New
- Duquesne Family Office
- Sold out
- Soros Fund Management
Q2 2024
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+2,813.8%)
Q1 2024
1 superinvestor holding at quarter end
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Lone Pine Capital